109 filings
Page 3 of 6
8-K
52doap9n
13 Sep 21
Regulation FD Disclosure
6:05am
8-K
8vt3rzl6sfbtux
10 Aug 21
Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
mix1r4buu4uvxxpr7gsl
10 May 21
Matinas BioPharma Reports First Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
oblfneiecohpg9g6
29 Mar 21
Matinas BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
6:35am
8-K
2u08v7v0p8hf6
1 Feb 21
Regulation FD Disclosure
6:03am
8-K
l2oicn17er2eb
27 Jan 21
Submission of Matters to a Vote of Security Holders
5:28pm
8-K
w1kqygb
14 Jan 21
Regulation FD Disclosure
7:00am
8-K
yowkbjbicxptgbysql4
28 Dec 20
Other Events
6:07am
8-K
ve0l0oia c94q
8 Dec 20
Regulation FD Disclosure
12:00am
8-K
jychq9
1 Dec 20
Matinas BioPharma Appoints Hui Liu, Ph.D., M.B.A. as Chief Technology Officer
5:05pm
8-K
za25wez 6l03w
25 Nov 20
Entry into a Material Definitive Agreement
4:00pm
8-K
0v6o0ro
6 Nov 20
Matinas BioPharma Reports Third Quarter 2020 Financial Results and Operational Highlights
7:55am
8-K
fiw10 2edeea6vl
4 Nov 20
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
1js93wcf0h7bas 1qe5
19 Oct 20
Regulation FD Disclosure
6:35am
8-K
7casskn
15 Sep 20
Matinas BioPharma Appoints Industry Veteran Natasha Giordano to Board of Directors
4:45pm
8-K
vqmoxdz pvg4ej5ixfe
10 Aug 20
Matinas BioPharma Reports Second Quarter 2020 Financial Results and Operational Highlights
4:05pm
8-K
tr2yktolh1j9
2 Jul 20
Entry into a Material Definitive Agreement
5:09pm
8-K
ax1z3 j19
2 Jun 20
Regulation FD Disclosure
8:00am
8-K
z42iy30
11 May 20
Matinas BioPharma Reports First Quarter 2020 Financial Results and Operational Highlights
5:18pm
8-K
o1kr7
9 Mar 20
Matinas BioPharma Reports Fourth Quarter and Full Year 2019
4:28pm